vs

Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and NGL Energy Partners LP (NGL). Click either name above to swap in a different company.

NGL Energy Partners LP is the larger business by last-quarter revenue ($909.8M vs $493.8M, roughly 1.8× Pediatrix Medical Group, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 5.2%, a 1.6% gap on every dollar of revenue. On growth, Pediatrix Medical Group, Inc. posted the faster year-over-year revenue change (-1.7% vs -41.3%). Over the past eight quarters, Pediatrix Medical Group, Inc.'s revenue compounded faster (-0.1% CAGR vs -6.4%).

Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.

NGL Energy Partners LP is a U.S.-based midstream energy services firm. It offers transportation, storage, and logistics solutions for crude oil, natural gas liquids, and renewable fuels, plus water management services for upstream energy producers, operating primarily across North American markets.

MD vs NGL — Head-to-Head

Bigger by revenue
NGL
NGL
1.8× larger
NGL
$909.8M
$493.8M
MD
Growing faster (revenue YoY)
MD
MD
+39.6% gap
MD
-1.7%
-41.3%
NGL
Higher net margin
MD
MD
1.6% more per $
MD
6.8%
5.2%
NGL
Faster 2-yr revenue CAGR
MD
MD
Annualised
MD
-0.1%
-6.4%
NGL

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
MD
MD
NGL
NGL
Revenue
$493.8M
$909.8M
Net Profit
$33.7M
$47.2M
Gross Margin
29.0%
Operating Margin
9.9%
12.1%
Net Margin
6.8%
5.2%
Revenue YoY
-1.7%
-41.3%
Net Profit YoY
10.5%
249.3%
EPS (diluted)
$0.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MD
MD
NGL
NGL
Q4 25
$493.8M
$909.8M
Q3 25
$492.9M
$674.7M
Q2 25
$468.8M
$622.2M
Q1 25
$458.4M
$971.1M
Q4 24
$502.4M
$982.4M
Q3 24
$511.2M
$756.5M
Q2 24
$504.3M
$759.2M
Q1 24
$495.1M
$1.0B
Net Profit
MD
MD
NGL
NGL
Q4 25
$33.7M
$47.2M
Q3 25
$71.7M
$29.3M
Q2 25
$39.3M
$68.9M
Q1 25
$20.7M
$13.7M
Q4 24
$30.5M
$13.5M
Q3 24
$19.4M
$2.5M
Q2 24
$-153.0M
$9.7M
Q1 24
$4.0M
$-236.8M
Gross Margin
MD
MD
NGL
NGL
Q4 25
29.0%
Q3 25
37.6%
Q2 25
38.5%
Q1 25
26.9%
Q4 24
25.1%
Q3 24
30.9%
Q2 24
29.0%
Q1 24
21.8%
Operating Margin
MD
MD
NGL
NGL
Q4 25
9.9%
12.1%
Q3 25
13.8%
14.0%
Q2 25
12.8%
15.7%
Q1 25
7.0%
8.4%
Q4 24
7.8%
8.6%
Q3 24
6.6%
10.8%
Q2 24
-31.3%
10.8%
Q1 24
3.2%
-9.4%
Net Margin
MD
MD
NGL
NGL
Q4 25
6.8%
5.2%
Q3 25
14.5%
4.3%
Q2 25
8.4%
11.1%
Q1 25
4.5%
1.4%
Q4 24
6.1%
1.4%
Q3 24
3.8%
0.3%
Q2 24
-30.3%
1.3%
Q1 24
0.8%
-22.8%
EPS (diluted)
MD
MD
NGL
NGL
Q4 25
$0.40
Q3 25
$0.84
Q2 25
$0.46
Q1 25
$0.24
Q4 24
$0.37
Q3 24
$0.23
Q2 24
$-1.84
Q1 24
$0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MD
MD
NGL
NGL
Cash + ST InvestmentsLiquidity on hand
$375.2M
$6.5M
Total DebtLower is stronger
$570.5M
$2.9B
Stockholders' EquityBook value
$865.9M
Total Assets
$2.2B
$4.4B
Debt / EquityLower = less leverage
0.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MD
MD
NGL
NGL
Q4 25
$375.2M
$6.5M
Q3 25
$340.1M
$8.7M
Q2 25
$224.7M
$5.4M
Q1 25
$99.0M
$13.5M
Q4 24
$229.9M
$5.7M
Q3 24
$103.8M
$4.5M
Q2 24
$19.4M
$5.3M
Q1 24
$8.0M
$38.9M
Total Debt
MD
MD
NGL
NGL
Q4 25
$570.5M
$2.9B
Q3 25
$577.2M
$2.9B
Q2 25
$583.9M
$2.9B
Q1 25
$590.5M
$3.0B
Q4 24
$597.1M
$3.1B
Q3 24
$3.1B
Q2 24
$3.0B
Q1 24
$2.9B
Stockholders' Equity
MD
MD
NGL
NGL
Q4 25
$865.9M
Q3 25
$890.7M
Q2 25
$833.8M
Q1 25
$789.2M
Q4 24
$764.9M
Q3 24
$732.5M
Q2 24
$706.5M
Q1 24
$856.2M
Total Assets
MD
MD
NGL
NGL
Q4 25
$2.2B
$4.4B
Q3 25
$2.2B
$4.3B
Q2 25
$2.1B
$4.2B
Q1 25
$2.0B
$4.6B
Q4 24
$2.2B
$4.8B
Q3 24
$2.1B
$4.9B
Q2 24
$2.0B
$4.8B
Q1 24
$2.2B
$5.0B
Debt / Equity
MD
MD
NGL
NGL
Q4 25
0.66×
Q3 25
0.65×
Q2 25
0.70×
Q1 25
0.75×
Q4 24
0.78×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MD
MD
NGL
NGL
Operating Cash FlowLast quarter
$114.1M
$182.3M
Free Cash FlowOCF − Capex
$45.7M
FCF MarginFCF / Revenue
5.0%
Capex IntensityCapex / Revenue
15.0%
Cash ConversionOCF / Net Profit
3.39×
3.86×
TTM Free Cash FlowTrailing 4 quarters
$126.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MD
MD
NGL
NGL
Q4 25
$114.1M
$182.3M
Q3 25
$137.3M
$40.5M
Q2 25
$137.2M
$33.2M
Q1 25
$-117.5M
$155.0M
Q4 24
$133.0M
$153.8M
Q3 24
$91.8M
$6.7M
Q2 24
$107.0M
$-18.1M
Q1 24
$-125.2M
$152.2M
Free Cash Flow
MD
MD
NGL
NGL
Q4 25
$45.7M
Q3 25
$9.5M
Q2 25
$11.1M
Q1 25
$60.4M
Q4 24
$152.1M
Q3 24
$-82.9M
Q2 24
$-78.0M
Q1 24
$119.8M
FCF Margin
MD
MD
NGL
NGL
Q4 25
5.0%
Q3 25
1.4%
Q2 25
1.8%
Q1 25
6.2%
Q4 24
15.5%
Q3 24
-11.0%
Q2 24
-10.3%
Q1 24
11.5%
Capex Intensity
MD
MD
NGL
NGL
Q4 25
15.0%
Q3 25
4.6%
Q2 25
3.6%
Q1 25
9.7%
Q4 24
0.2%
Q3 24
11.8%
Q2 24
7.9%
Q1 24
3.1%
Cash Conversion
MD
MD
NGL
NGL
Q4 25
3.39×
3.86×
Q3 25
1.91×
1.38×
Q2 25
3.49×
0.48×
Q1 25
-5.66×
11.29×
Q4 24
4.36×
11.39×
Q3 24
4.72×
2.74×
Q2 24
-1.87×
Q1 24
-31.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MD
MD

Health Care Patient Service$421.6M85%
Hospitals Contracts$70.0M14%
Other$2.2M0%

NGL
NGL

Water Solutions Segment$208.6M23%
Services$193.3M21%
Butane$192.5M21%
Service Fees$182.8M20%
Public Utilities Inventory Propane$93.9M10%
Crude Oil$23.3M3%
Crude Oil Transportation And Other$6.5M1%
Liquids Logistics Segment$2.5M0%
Crude Oil Logistics Segment$1.2M0%

Related Comparisons